Regals Capital Management Lp - Net Worth and Insider Trading
Regals Capital Management Lp Net Worth
The estimated net worth of Regals Capital Management Lp is at least $3 Million dollars as of 2024-11-13. Regals Capital Management Lp is the 10% Owner of Oramed Pharmaceuticals Inc and owns about 1,453,637 shares of Oramed Pharmaceuticals Inc (ORMP) stock worth over $3 Million. Details can be seen in Regals Capital Management Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Regals Capital Management Lp has not made any transactions after 2014-06-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Regals Capital Management Lp
Regals Capital Management Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Regals Capital Management Lp owns 2 companies in total, including Oramed Pharmaceuticals Inc (ORMP) , and Legend International Holdings Inc (LGDIQ) .
Click here to see the complete history of Regals Capital Management Lp’s form 4 insider trades.
Insider Ownership Summary of Regals Capital Management Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ORMP | Oramed Pharmaceuticals Inc | 2014-06-06 | 10 percent owner |
| LGDIQ | Legend International Holdings Inc | 2013-02-19 | 10 percent owner |
Regals Capital Management Lp Latest Holdings Summary
Regals Capital Management Lp currently owns a total of 1 stock. Regals Capital Management Lp owns 1,453,637 shares of Oramed Pharmaceuticals Inc (ORMP) as of June 6, 2014, with a value of $3 Million.
Latest Holdings of Regals Capital Management Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ORMP | Oramed Pharmaceuticals Inc | 2014-06-06 | 1,453,637 | 2.34 | 3,401,511 |
Holding Weightings of Regals Capital Management Lp
Regals Capital Management Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Regals Capital Management Lp has made a total of 0 transactions in Oramed Pharmaceuticals Inc (ORMP) over the past 5 years. The most-recent trade in Oramed Pharmaceuticals Inc is the acquisition of 2,252 shares on June 6, 2014, which cost Regals Capital Management Lp around $9,999.
Insider Trading History of Regals Capital Management Lp
- 1
Regals Capital Management Lp Trading Performance
GuruFocus tracks the stock performance after each of Regals Capital Management Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Regals Capital Management Lp is -12.85%. GuruFocus also compares Regals Capital Management Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Regals Capital Management Lp within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Regals Capital Management Lp's insider trading performs compared to the benchmark.
Performance of Regals Capital Management Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.17 | | | | | |
| Relative Return to S&P 500(%) | 5.69 | | | | | |
Regals Capital Management Lp Ownership Network
Ownership Network List of Regals Capital Management Lp
Ownership Network Relation of Regals Capital Management Lp
Regals Capital Management Lp Owned Company Details
What does Oramed Pharmaceuticals Inc do?
Who are the key executives at Oramed Pharmaceuticals Inc?
Regals Capital Management Lp is the 10 percent owner of Oramed Pharmaceuticals Inc. Other key executives at Oramed Pharmaceuticals Inc include director & 10 percent owner Nadav Kidron , Chief Commercial Officer Michael Rabinowitz , and Chief Financial Officer David Silberman .
Oramed Pharmaceuticals Inc (ORMP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oramed Pharmaceuticals Inc (ORMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oramed Pharmaceuticals Inc (ORMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oramed Pharmaceuticals Inc (ORMP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oramed Pharmaceuticals Inc Insider Transactions
Regals Capital Management Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Regals Capital Management Lp. You might contact Regals Capital Management Lp via mailing address: 152 West 57th Street, 9th Floor, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
